Nu-Med Plus (NUMD) Cash & Current Investments (2011 - 2025)
Nu-Med Plus (NUMD) posted Cash & Current Investments of $661.0 for Q4 2025, down 66.07% sequentially from $1948.0 in Q3 2025, and down 72.14% YoY from $2373.0 in Q4 2024.
Nu-Med Plus (NUMD) Cash & Current Investments (2011 - 2025) Analysis & Trends
Nu-Med Plus has reported Cash & Current Investments for 15 years, with the latest figure at $661.0 in Q4 2025.
- Quarterly Cash & Current Investments fell 72.14% year-over-year to $661.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $661.0 (down 72.14% YoY) and the FY2025 annual result came in at $661.0, down 72.14% from the prior year.
- Cash & Current Investments fell to $661.0 in Q4 2025 per NUMD's latest filing, from $1948.0 in the prior quarter.
- Over five years, Cash & Current Investments peaked at $139265.0 in Q1 2021 and troughed at $628.0 in Q3 2022.
- A 5-year average of $23974.1 and a median of $6356.0 in 2024 frame the typical range for Cash & Current Investments.
- The sharpest annual moves came in 2022 and 2023: Cash & Current Investments sank 98.18% in 2022, then soared 1990.22% in 2023.
- Over 5 years, Cash & Current Investments stood at $11675.0 in 2021, then surged by 526.94% to $73195.0 in 2022, then slumped by 90.7% to $6806.0 in 2023, then tumbled by 65.13% to $2373.0 in 2024, then slumped by 72.14% to $661.0 in 2025.
- According to Business Quant data, Cash & Current Investments over the past three periods registered $661.0, $1948.0, and $863.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.45 Bn | 193.85 Bn | 7.27 Bn | 5.60 Bn |
| 2 | Stryker | 127.62 Bn | 124.14 Bn | 4.50 Bn | 3.48 Bn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 9.22 Bn |
| 4 | Boston Scientific | 73.41 Bn | 72.87 Bn | 3.85 Bn | 539.00 Mn |
| 5 | Edwards Lifesciences | 51.89 Bn | 47.64 Bn | 1.35 Bn | 4.25 Bn |
| 6 | Dexcom | 34.33 Bn | 32.38 Bn | 830.00 Mn | 1.95 Bn |
| 7 | GE HealthCare Technologies | 33.87 Bn | 31.76 Bn | 2.18 Bn | 2.11 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 3.32 Bn |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | 482.30 Mn |
| 10 | Nu-Med Plus | 2.03 Mn | 2.02 Mn | - | 5,409.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 661.00 |
| Sep 30, 2025 | 1,948.00 |
| Jun 30, 2025 | 863.00 |
| Mar 31, 2025 | 2,373.00 |
| Dec 31, 2024 | 2,373.00 |
| Sep 30, 2024 | 4,041.00 |
| Jun 30, 2024 | 4,041.00 |
| Mar 31, 2024 | 6,356.00 |
| Dec 31, 2023 | 6,806.00 |
| Sep 30, 2023 | 11,088.00 |
| Jun 30, 2023 | 29,957.00 |
| Mar 31, 2023 | 53,029.00 |
| Dec 31, 2022 | 73,195.00 |
| Sep 30, 2022 | 628.00 |
| Mar 31, 2022 | 2,537.00 |
| Dec 31, 2021 | 11,675.00 |
| Sep 30, 2021 | 31,840.00 |
| Jun 30, 2021 | 72,831.00 |
| Mar 31, 2021 | 139,265.00 |
| Dec 31, 2020 | 188,506.00 |